📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-01 19:45
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Natural Biocon MD and CS Resign; Board Cancels Three Prior Director Appointments
Natural Biocon (India) Ltd announced that its Board of Directors accepted the resignations of Managing Director Arunkumar Dashrathbhai Prajapati and Company Secretary Shruti Sharma, both effective retrospectively from September 26, 2026. Additionally, the Board decided to cancel and withdraw previous disclosures regarding the appointments of two Independent Directors (effective June 6, 2026) and the AGM Scrutinizer. This leadership vacuum hits a micro-cap company with a market cap of just Rs 5 Cr and a declining revenue base (FY26 revenue fell to Rs 2.55 Cr with an annual net loss of Rs 0.03 Cr).
Confidence: HIGH
What changedManaging Director and Company Secretary have stepped down, while the company abruptly withdrew earlier appointments of two Independent Directors and an AGM scrutinizer.
Why it mattersSimultaneous departure of executive leadership and cancellation of board appointments signals governance distress and instability in an already loss-making micro-cap with only 9.4% promoter holding.
MD Resignation Effective Date: 26 September 2026CS Resignation Effective Date: 26 September 2026Withdrawn Director Appointments Effective Date: 06 June 2026Market Capitalization: Rs 5 Cr
📅 Short termHeightened uncertainty and negative sentiment regarding company leadership, secretarial compliance, and potential regulatory scrutiny over delayed disclosures.
📈 Long termStructural governance overhang; company lacks key managerial personnel amidst collapsing revenue (down from Rs 17.04 Cr in FY24 to Rs 2.55 Cr in FY26).
⚠ Risk flags
- Simultaneous loss of Managing Director and Company Secretary
- Sudden withdrawal of Independent Director appointments indicating boardroom instability
- Extremely low promoter holding (9.36%) with negative operating margins (-1.2%)
Key Highlights
Resignation of Managing Director Arunkumar Dashrathbhai Prajapati effective 26 September 2026
Resignation of Company Secretary Shruti Sharma effective 26 September 2026
Cancellation/withdrawal of appointments for 2 Additional Independent Directors originally effective 06 June 2026
Withdrawal of disclosure regarding appointment of Scrutinizer for AGM e-voting
Micro-cap context: market capitalization stands at Rs 5 Cr with FY26 revenue of Rs 2.55 Cr
👀 What to Watch
Monitor upcoming regulatory filings for the appointment of a new Managing Director and Compliance Officer to gauge governance stability and statutory compliance.
Natural Biocon MD Arun Kumar Dashrathbhai Prajapati Resigns Effective September 26, 2026
Natural Biocon (India) Ltd announced that its Managing Director, Arun Kumar Dashrathbhai Prajapati, has resigned from the board effective close of business hours on September 26, 2026. The cited reason is increased professional commitments and time constraints, with no other material reasons reported. The departing Managing Director holds NIL shares in the micro-cap company (market cap Rs 5 Cr). This leadership exit occurs as the company operates at a modest scale, generating TTM revenue of just Rs 3 Cr.
Confidence: HIGH
What changedManaging Director Arun Kumar Dashrathbhai Prajapati stepped down from the board effective September 26, 2026.
Why it mattersThe exit of the top executive creates a leadership vacuum in a micro-cap company currently facing declining revenues (down to Rs 2.55 Cr in FY26 from Rs 17.04 Cr in FY24).
Effective Date of Cessation: September 26, 2026Shareholding of Outgoing MD: NILMarket Cap: Rs 5 CrTTM Revenue: Rs 3 Cr
📅 Short termMay weigh on sentiment given leadership uncertainty at an already struggling micro-cap firm.
📈 Long termCrucial to see who takes over operational management to stabilize revenues, which contracted sharply over the past three fiscal years.
⚠ Risk flags
- Key management departure without immediate successor named
- Low promoter holding at 9.36%
- Deteriorating revenue trajectory over FY24-FY26
Key Highlights
Managing Director Arun Kumar Dashrathbhai Prajapati resigned with effect from September 26, 2026
Reason cited is increased professional commitments and time constraints
Outgoing Managing Director holds NIL shares in the company
Departure comes amidst micro-cap scale with Rs 5 Cr market cap and TTM revenue of Rs 3 Cr
👀 What to Watch
Monitor upcoming board announcements regarding the appointment of a new Managing Director or leadership succession plan.
Natural Biocon Q1 Results: Revenue Drops to Nil, Reports Net Loss of ₹1.16 Lakh
Natural Biocon (India) Ltd reported zero operational revenue for the quarter ended June 30, 2026, down from ₹166.57 lakh in the corresponding quarter of the previous year. The company posted a net loss of ₹1.16 lakh compared to a net profit of ₹13.86 lakh in Q1 FY26. Total expenses declined sharply to ₹1.16 lakh (vs ₹152.71 lakh in Q1 FY26) due to the absence of trading and purchase activity. Additionally, the board approved the resignation of statutory auditor M/s Mayur Shah & Associates and appointed M/s Nirav S Shah & Co.
Confidence: HIGH
What changedThe company reported zero revenue for the quarter and approved a change in statutory auditors.
Why it mattersDemonstrates near-complete lack of business activity during the period for a micro-cap company with low promoter holding.
Revenue from operations: ₹0.00 lakhNet Loss: ₹1.16 lakhPrior-year Q1 Revenue: ₹166.57 lakhPrior-year Q1 PAT: ₹13.86 lakhPaid up Equity Share Capital: ₹2578.28 lakh
📅 Short termWeak operational print and lack of turnover may keep investor sentiment subdued.
📈 Long termLimited viability unless company can consistently revive top-line operations and generate cash flow.
⚠ Risk flags
- Zero operational revenue during the quarter
- Statutory auditor resignation
- Low promoter holding (9.36%)
Key Highlights
Revenue from operations was ₹0.00 lakh vs ₹166.57 lakh in Q1 FY26
Net loss stood at ₹1.16 lakh against a net profit of ₹13.86 lakh in Q1 FY26
Total expenses dropped to ₹1.16 lakh compared to ₹152.71 lakh in the previous year quarter
Paid-up equity share capital stood unchanged at ₹2,578.28 lakh
M/s Nirav S Shah & Co appointed as Statutory Auditors w.e.f. August 1, 2026 following resignation of M/s Mayur Shah & Associates
👀 What to Watch
Track whether commercial operations and trading activities restart in subsequent quarters to evaluate operational viability.
Natural Biocon Reports Nil Revenue and Rs 1.16 Lakh Loss in Q1; Appoints New Auditor
Natural Biocon (India) Ltd reported zero revenue from operations for the quarter ended June 30, 2026, down sharply from Rs 1.67 Cr (Rs 166.57 Lakhs) in Q1 FY26 and Rs 0.88 Cr in Q4 FY26. The company posted a net loss of Rs 1.16 Lakhs against a net profit of Rs 13.86 Lakhs in the corresponding quarter of the previous year. Total expenses dropped to Rs 1.16 Lakhs due to lack of trading activity. Additionally, the Board approved the resignation of statutory auditor M/s Mayur Shah & Associates and appointed M/s Nirav S Shah & Co.
Confidence: HIGH
What changedReported zero operational revenue for Q1 ended June 30, 2026, alongside a transition in statutory auditors.
Why it mattersReflects an operational standstill in business activities for a microcap with already low promoter shareholding (9.36%), impacting revenue visibility.
Revenue from operations (Q1): Rs 0.00 LakhsNet Loss (Q1): Rs 1.16 LakhsYoY Revenue (Q1 FY26): Rs 166.57 LakhsYoY Net Profit (Q1 FY26): Rs 13.86 LakhsPaid up Equity Share Capital: Rs 2578.28 Lakhs
📅 Short termLikely to weigh negatively on sentiment due to zero sales and auditor turnover.
📈 Long termLimited visibility unless company demonstrates sustainable business revival and transparent operational cash flows.
⚠ Risk flags
- Zero revenue generated during the quarter indicating stalled core operations
- Low promoter holding of 9.36%
- Statutory auditor resignation
Key Highlights
Revenue from operations fell to Rs 0.00 Lakhs in Q1 ended June 30, 2026, compared to Rs 166.57 Lakhs in Q1 FY26.
Net loss recorded at Rs 1.16 Lakhs versus a net profit of Rs 13.86 Lakhs in Q1 FY26.
Total expenses stood at Rs 1.16 Lakhs, driven by Rs 1.06 Lakhs in other expenses and Rs 0.10 Lakhs in depreciation.
Resignation of Statutory Auditor M/s Mayur Shah & Associates effective July 31, 2026, and appointment of M/s Nirav S Shah & Co effective August 1, 2026.
👀 What to Watch
Track subsequent quarterly filings to see if commercial operations resume and monitor disclosures regarding reasons behind the statutory auditor resignation.
